HCW Biologics Inc. Common Stock (HCWB)
Stock · NASDAQ · Health Care
$1.23as of 10/16/2026
Price chart
Active signals
HCWB Signal Track Record
How signals performed across all stocks →What HCWB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 24 | -10.1% | 38% | August 18, 2026 |
| Bollinger Band Breakout | 15 | -14.1% | 20% | May 15, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -12.0% | 0% | May 28, 2026 |
| Volume Spike | 8 | -13.5% | 25% | September 24, 2026 |
| Any 20-session window (baseline) | -7.6% | 33% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HCWB
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2)…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 35
- Website
- hcwbiologics.com/
Fundamentals
- 1-day range
- $1.15$1.28
- Market cap
- $6.19M
- P/E (trailing)
- —
- P/E (forward)
- -2.24
- EPS (trailing)
- $-10.91
- Dividend yield
- —
- Beta
- 2.28
- Avg. volume
- 415.1K
How HCW Biologics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
HCW Biologics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HCWBHCW Biologics Inc. Common Stock$1.24▲ 0.81%Market cap $6.19MP/E —$1.14$27.3
- APVOAptevo Therapeutics Inc. Common Stock$1.62▼ 4.71%Market cap $6.18MP/E 0.00$1.37$30.06
- GELSGelteq Limited Ordinary Shares$0.446▲ 3.48%Market cap $6.15MP/E —$0.387$2.01
- ACXPAcurx Pharmaceuticals Inc. Common Stock$1.1▼ 5.98%Market cap $6.27MP/E —$1.15$7.87
- ENVBEnveric Biosciences Inc. Common Stock$1.38▼ 0.72%Market cap $6.28MP/E —$1.17$13.25
- PULMPulmatrix Inc. Common Stock$1.36▼ 3.55%Market cap $6.06MP/E —$1.16$5.24
- XBIOXenetic Biosciences Inc. Common Stock$1.99▼ 1.00%Market cap $6.53MP/E —$1.87$5.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HCWB HCW Biologics Inc. Common Stock | $6.19M | — | $1.24 | ▲ 0.81% | $1.14$27.3 |
| APVO Aptevo Therapeutics Inc. Common Stock | $6.18M | 0.00 | $1.62 | ▼ 4.71% | $1.37$30.06 |
| GELS Gelteq Limited Ordinary Shares | $6.15M | — | $0.446 | ▲ 3.48% | $0.387$2.01 |
| ACXP Acurx Pharmaceuticals Inc. Common Stock | $6.27M | — | $1.1 | ▼ 5.98% | $1.15$7.87 |
| ENVB Enveric Biosciences Inc. Common Stock | $6.28M | — | $1.38 | ▼ 0.72% | $1.17$13.25 |
| PULM Pulmatrix Inc. Common Stock | $6.06M | — | $1.36 | ▼ 3.55% | $1.16$5.24 |
| XBIO Xenetic Biosciences Inc. Common Stock | $6.53M | — | $1.99 | ▼ 1.00% | $1.87$5.28 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- HCW Biologics Says IND Filing For Solid Tumor Drug HCW11-018b On Track For 1H 2027 After FDA Meetingbenzinga · 10/9/2026
- HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid TumorsYahoo · 10/9/2026
- HCW Biologics Files Prospectus For Resale Of Up To 1,807,228 Shares Underlying Armistice Capital WarrantsBenzinga · 10/2/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 9/25/2026
- HCW Biologics Announces Pricing of $1.5 Million Private PlacementYahoo · 9/24/2026
- HCW Biologics Prices $1.5M Private Placement Of 903,614 Units At $1.6599 Per UnitBenzinga · 9/24/2026
Insider Activity
Insider Actions →- Hing C. Wong · July 29, 2026 · Buy23.2K @ $2.59
- Lee Flowers · July 29, 2026 · Buy7.7K @ $2.59
- Scott T. Garrett · July 29, 2026 · Buy7.7K @ $2.59
- Hing C. Wong · May 22, 2026 · Buy113.9K @ $1.41
- Rebecca Byam · May 22, 2026 · Buy14.2K @ $1.41
- Scott T. Garrett · May 22, 2026 · Buy177.9K @ $1.41
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
HCW Biologics Included in After-Market Movers List
HCW Biologics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with technical indicators showing oversold conditions. This inclusion highlights recent price volatility, though no specific catalyst for the move was detailed in the provided news.
HCW Biologics Included in After-Market Movers List. HCW Biologics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with technical indicators showing oversold conditions. This inclusion highlights recent price volatility, though no specific catalyst for the move was detailed in the provided news.